1-877-892-3553

C'ELLE : YOUR MONTHLY MIRACLE

Science Showcase

Comparative Matrix for Menstrual Stromal Cells and Bone Marrow Mesenchymal Cells

Cell Characteristics

C’elle (Menstrual Stromal Cells)

BM MSC (Bone Marrow Mesenchymal Cells)

Cell Collection Procedure

Non-invasive menstrual cup similar to insertion of a tampon

Harvest bone marrow in the OR mobilized adult peripheral blood

Cell Morphology

stromal, mesenchymal-like, spindle-shaped in culture

stromal, mesenchymal-like,  spindle-shaped in culture (4)

Cell Surface Markers associated with mesenchymal cells

CD29, CD44, CD73, CD90, CD105, CD166
MHC I+ MHC II-

CD29, CD44, CD73, CD90, CD105, CD166
MHC I+ MHC II- (1)(3)

Markers associated with embryonic stem cells

SSEA-4, Oct-4

none

Differentiation capability

Neural, Cardiogenic, Chondrogenic, Adipogenic, Osteogenic

Chondrogenic, Adipogenic, Osteogenic (2)

MLR

Cells demonstarted a weak stimulatory response which suggests potential use in first-degree relatives

Do not elicit alloreactive lymphocyte proliferative responses (1)

Karotype

Normal karyotype

Normal Karyotye (3)

CD 117 positive

Yes

Yes (7,8,9)

References:

  1. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, & Ringdén O. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 31(10), 890-896.
  2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999). Multilineage potential of adult human mesenchymal stem cells.  Science, 284(5411), 143-147.
  3. Kern S, Eichler H, Stoeve J, Klüter H, Bieback, K. (2006). Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue. Stem Cells, 24(5), 1294 –1301.
  4. Horwitz, Edwin M. (2007). Report on the Workshop "New Technologies in Stem Cell Research," Society  for Pediatric Research, San Francisco, California, April 29, 2006, Fundamentals of MSC Isolation and Purification.Stem Cells, 25(4), 1070 -1088.
  5. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med, 355(12), 1210-1221.
  6. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med, 5, 309–313.
  7. Gentry, T; Foster, SJ.; Winstead, L; Deibert, E; Fiordalisi, M; Balber, AE. Simultaneous isolation of human bone marrow hematopoietic, endothelial, and mesenchymal progenitor cells by flow sorting based on ahlehyde dehydrogenase activity. (2006) Blood (108;11, part 1), 1043A
  8. Urbaniak-Kujda, D; Wolowiec, D; Tomaszewska-Toporska, B; Kapelko-Slowik, K; Kuliczkowski, K. Mesenchymal stem cells: biology, and perspectives of clinical use.(2005) Acta Haematologica Polonica 36(2), 161-166
  9. Lange, C; Gehling, U; Moosmann, S; Huss, R; Zander, AR. Blood from mesenchymal stem cell. (2004) Blood (104; 11, part 1), 644A